Efficacy and safety of dinutuximab beta combined with GM-CSF and isotretinoin ± chemotherapy as first-line maintenance treatment for pediatric high-risk neuroblastoma in China

BackgroundReal-world evidence on dinutuximab beta for high-risk neuroblastoma (NB) in the Chinese pediatric patients remains limited. This study evaluated clinical efficacy and safety of dinutuximab beta as first-line maintenance therapy in a real-world setting.MethodsWe retrospectively analyzed ped...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Wen Zhao, Peiyi Yang, Jing Qin, Cheng Huang, Hongjun Fan, Mei Jin, Chao Duan, Ying Wu, Xisi Wang, Chunying Cui, Yan Su
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2026-02-01
Seria:	Frontiers in Oncology
Hasła przedmiotowe:	dinutuximab beta first-line maintenance GD2- antibody immunotherapy high-risk neuroblastoma pediatrics
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1765578/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!